vedsp | 13688
Vedolizumab (Entyvio®), level
Keywords
Entyvio
| Material |
|
|
| Min. quantity | 500 µL | |
| Stability | 4 days / 18-25°C; 4 weeks / 2-8°C; 1 year / -20°C | |
| Duration | 3 - 4 days | |
| Frequency | 5 x per week (monday - friday) | |
| Method | Liquid chromatography / mass spectrometry (LCMS) | |
| Price | CHF 135.00 | |
| Tariff | 135.00 TP | |
| LA position | 1469.00 | |
| Designation | Immunsuppressiva der SL/ALT inkl. Metabo | |
| Executing laboratory | External laboratory |
Team of consultants
|
Dr. sc. nat. ETH
Diana Ciardo
FAMH Specialist in laboratory medicine, main fields medical microbiology, immunology
|
FAMH Specialist in laboratory medicine, main fields medical microbiology, immunology | T |
|
|
MSc Infection Biology
Siro Ellenberger
Candidate FAMH Specialist in laboratory medicine, main field immunology
|
Candidate FAMH Specialist in laboratory medicine, main field immunology | T |
|
|
Dr. phil. II
Maurus Curti
FAMH Specialist in laboratory medicine, main fields Clinical Chemistry, Haematology, Immunology, Microbiology
|
FAMH Specialist in laboratory medicine, main fields Clinical Chemistry, Haematology, Immunology, Microbiology | T |
|
|
Dr. sc. nat.
Corinne Ruppen
FAMH Specialist in laboratory medicine, main field clinical chemistry
|
FAMH Specialist in laboratory medicine, main field clinical chemistry | T |
|